Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2015 Volume 12 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2015 Volume 12 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Fms‑like tyrosine kinase 3 ligand is required for thymic dendritic cell generation from bone marrow‑derived CD117+ hematopoietic progenitor cells

  • Authors:
    • Yunyun Xu
    • Dong Jiang
    • Yizhou Hu
    • Yiping Li
    • Xueguang Zhang
    • Jian Wang
    • Yong Wang
  • View Affiliations / Copyright

    Affiliations: Institute of Pediatrics, Children's Hospital Affiliated to Soochow University Suzhou, Jiangsu 215025, P.R. China, Stem Cell and Biomedical Material Key Laboratory of Jiangsu Province, State Key Laboratory Incubation Base, Soochow University, Suzhou, Jiangsu 215007, P.R. China, Department of Virology, The Haartman Institute, Molecular Cancer Biology Research Program and Helsinki University Hospital, University of Helsinki, Helsinki FIN‑00100, Finland, Department of Medicine, Division of Pulmonary Allergy and Critical Care Medicine, University of Alabama, Birmingham, AL 35233, USA
  • Pages: 6969-6975
    |
    Published online on: September 11, 2015
       https://doi.org/10.3892/mmr.2015.4320
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Thymic dendritic cells (TDCs) are a type of dendritic cell (DC) in the thymus, which can enhance the proliferation of thymic T lymphocytes, regulate negative selection and induce central tolerance through autoantigen presentation. However, further investigations using TDCs has been restricted due to insufficient numbers. Therefore, an effective expansion method for TDCs in vitro is urgently required to further examine their biological characteristics. In the present study, a novel system was established using fetal thymus organ culture (FTOC) and a hanging drop culture system in the presence of fms‑like tyrosine kinase 3 ligand (Flt3L), termed the Flt3L/FTOC system. TDCs were successfully generated and expanded from CD117+ bone marrow hematopoietic progenitor cells. Conventional DCs (cDCs; CD11c+B220‑ DCs) and plasmacytoid DCs (pDCs; CD11c+B220+ DCs) were found in the TDCs generated using the Flt3L/FTOC system. These cells exhibited the specific morphological features of DCs, which were confirmed using Giemsa staining. Furthermore, the cytokine and surface marker profiles were also analyzed. Higher expression levels of interferon‑α and interleukin‑12 were observed in the pDCs, compared with the cDCs, and higher expression levels of toll‑like receptor (TLR)7 and TLR9 were found in the pDCs than in the cDCs. In addition, the Flt3L/FTOC‑derived TDCs also exhibited the ability to stimulate the allogenic T cell response. In conclusion, a novel in vitro culture system of thymic cDCs and pDCs using Flt3L was established, and this may provide a methodological basis for understanding the properties of TDCs.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Lee HK and Iwasaki A: Innate control of adaptive immunity: Dendritic cells and beyond. Semin Immunol. 19:48–55. 2007. View Article : Google Scholar : PubMed/NCBI

2 

Shortman K and Naik SH: Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol. 7:19–30. 2007. View Article : Google Scholar

3 

Gilliet M, Boonstra A, Paturel C, Antonenko S, Xu XL, Trinchieri G, O'Garra A and Liu YJ: The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med. 195:953–958. 2002. View Article : Google Scholar : PubMed/NCBI

4 

Miller G, Pillarisetty VG, Shah AB, Lahrs S and DeMatteo RP: Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties. J Immunol. 170:3554–3564. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Luche H, Ardouin L, Teo P, See P, Henri S, Merad M, Ginhoux F and Malissen B: The earliest intrathymic precursors of CD8alpha (+) thymic dendritic cells correspond to myeloid-type double-negative 1c cells. Eur J Immunol. 41:2165–2175. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Ardavin C, Wu L, Li CL and Shortman K: Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature. 362:761–763. 1993. View Article : Google Scholar : PubMed/NCBI

7 

Kadowaki N, Antonenko S and Liu YJ: Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c-type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN. J Immunol. 166:2291–2295. 2001. View Article : Google Scholar : PubMed/NCBI

8 

Diebold SS, Kaisho T, Hemmi H, Akira S and Reis e Sousa C: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 303:1529–1531. 2004. View Article : Google Scholar : PubMed/NCBI

9 

Jarrossay D, Napolitani G, Colonna M, Sallusto F and Lanzavecchia A: Specialization and complementarity in microbial molecule recognition by human myeloid and plasma-cytoid dendritic cells. Eur J Immunol. 31:3388–3393. 2001. View Article : Google Scholar : PubMed/NCBI

10 

Bendriss-Vermare N, Barthélémy C, Durand I, Bruand C, Dezutter-Dambuyant C, Moulian N, Berrih-Aknin S, Caux C, Trinchieri G and Brière F: Human thymus contains IFN-alpha-producing CD11c (−), myeloid CD11c (+) and mature interdigitating dendritic cells. J Clin Invest. 107:8358442001. View Article : Google Scholar : PubMed/NCBI

11 

Gurney KB, Colantonio AD, Blom B, Spits H and Uittenbogaart CH: Endogenous IFN-alpha production by plasmacytoid dendritic cells exerts an antiviral effect on thymic HIV-1 infection. J Immunol. 173:7269–7276. 2004. View Article : Google Scholar : PubMed/NCBI

12 

Fohrer H, Audit IM, Sainz A, Schmitt C, Dezutter-Dambuyant C and Dalloul AH: Analysis of transcription factors in thymic and CD34+ progenitor-derived plasmacytoid and myeloid dendritic cells: Evidence for distinct expression profiles. Exp Hematol. 32:104–112. 2004. View Article : Google Scholar : PubMed/NCBI

13 

Keir ME, Stoddart CA, Linquist-Stepps V, Moreno ME and McCune JM: IFN-alpha secretion by type 2 predendritic cells up-regulates MHC class I in the HIV-1-infected thymus. J Immunol. 168:325–331. 2002. View Article : Google Scholar

14 

Varas A, Vicente A, Sacedón R and Zapata AG: Interleukin-7 influences the development of thymic dendritic cells. Blood. 92:93–100. 1998.PubMed/NCBI

15 

Adolfsson J, Borge OJ, Bryder D, Theilgaard-Mönch K, Astrand-Grundström I, Sitnicka E, Sasaki Y and Jacobsen SE: Upregulation of Flt3 expression within the bone marrow Lin (−) Sca1 (+) c-kit (+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity. 15:659–669. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K and McKenna HJ: Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J Exp Med. 184:1953–1962. 1996. View Article : Google Scholar : PubMed/NCBI

17 

O'Keeffe M, Hochrein H, Vremec D, Pooley J, Evans R, Woulfe S and Shortman K: Effects of administration of progeni-poietin 1, Flt-3 ligand, granulocyte colony-stimulating factor and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood. 99:2122–2130. 2002. View Article : Google Scholar : PubMed/NCBI

18 

Chen W, Antonenko S, Sederstrom JM, Liang X, Chan AS, Kanzler H, Blom B, Blazar BR and Liu YJ: Thrombopoietin cooperates with FLT3-ligand in the generation of plasma-cytoid dendritic cell precursors from human hematopoietic progenitors. Blood. 103:2547–2553. 2004. View Article : Google Scholar

19 

Suss G and Shortman K: A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med. 183:1789–1796. 1996. View Article : Google Scholar : PubMed/NCBI

20 

Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, Homey B, Barrat FJ, Zal T and Gilliet M: Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med. 206:1983–1994. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Cella M, Sallusto F and Lanzavecchia A: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol. 9:10–16. 1997. View Article : Google Scholar : PubMed/NCBI

22 

Romani N, Reider D, Heuer M, Ebner S, Kämpgen E, Eibl B, Niederwieser D and Schuler G: Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods. 196:137–151. 1996. View Article : Google Scholar : PubMed/NCBI

23 

Zhou LJ and Tedder TF: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA. 93:2588–2592. 1996. View Article : Google Scholar : PubMed/NCBI

24 

Kingston D, Schmid MA, Onai N, Obata-Onai A, Baumjohann D and Manz MG: The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood. 114:835–843. 2009. View Article : Google Scholar : PubMed/NCBI

25 

McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, Maliszewski CR, Lynch DH, Smith J, Pulendran B, et al: Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells and natural killer cells. Blood. 95:3489–3497. 2000.PubMed/NCBI

26 

Sambandam A, Maillard I, Zediak VP, Xu L, Gerstein RM, Aster JC, Pear WS and Bhandoola A: Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol. 6:663–670. 2005. View Article : Google Scholar : PubMed/NCBI

27 

de Kruijf EJ, Hagoort H, Velders GA, Fibbe WE and van Pel M: Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administration. Haematologica. 95:1061–1067. 2010. View Article : Google Scholar : PubMed/NCBI

28 

Karsunky H, Merad M, Cozzio A, Weissman IL and Manz MG: Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J Exp Med. 198:305–313. 2003. View Article : Google Scholar : PubMed/NCBI

29 

Kim T, Pazhoor S, Bao M, Zhang Z, Hanabuchi S, Facchinetti V, Bover L, Plumas J, Chaperot L, Qin J and Liu YJ: Aspartate-g lutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc Natl Acad Sci USA. 107:15181–15186. 2010. View Article : Google Scholar

30 

Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG, Larsson M, Gorelick RJ, Lifson JD and Bhardwaj N: Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest. 115:3265–3275. 2005. View Article : Google Scholar : PubMed/NCBI

31 

Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H and Bauer S: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 303:1526–1529. 2004. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xu Y, Jiang D, Hu Y, Li Y, Zhang X, Wang J and Wang Y: Fms‑like tyrosine kinase 3 ligand is required for thymic dendritic cell generation from bone marrow‑derived CD117+ hematopoietic progenitor cells. Mol Med Rep 12: 6969-6975, 2015.
APA
Xu, Y., Jiang, D., Hu, Y., Li, Y., Zhang, X., Wang, J., & Wang, Y. (2015). Fms‑like tyrosine kinase 3 ligand is required for thymic dendritic cell generation from bone marrow‑derived CD117+ hematopoietic progenitor cells. Molecular Medicine Reports, 12, 6969-6975. https://doi.org/10.3892/mmr.2015.4320
MLA
Xu, Y., Jiang, D., Hu, Y., Li, Y., Zhang, X., Wang, J., Wang, Y."Fms‑like tyrosine kinase 3 ligand is required for thymic dendritic cell generation from bone marrow‑derived CD117+ hematopoietic progenitor cells". Molecular Medicine Reports 12.5 (2015): 6969-6975.
Chicago
Xu, Y., Jiang, D., Hu, Y., Li, Y., Zhang, X., Wang, J., Wang, Y."Fms‑like tyrosine kinase 3 ligand is required for thymic dendritic cell generation from bone marrow‑derived CD117+ hematopoietic progenitor cells". Molecular Medicine Reports 12, no. 5 (2015): 6969-6975. https://doi.org/10.3892/mmr.2015.4320
Copy and paste a formatted citation
x
Spandidos Publications style
Xu Y, Jiang D, Hu Y, Li Y, Zhang X, Wang J and Wang Y: Fms‑like tyrosine kinase 3 ligand is required for thymic dendritic cell generation from bone marrow‑derived CD117+ hematopoietic progenitor cells. Mol Med Rep 12: 6969-6975, 2015.
APA
Xu, Y., Jiang, D., Hu, Y., Li, Y., Zhang, X., Wang, J., & Wang, Y. (2015). Fms‑like tyrosine kinase 3 ligand is required for thymic dendritic cell generation from bone marrow‑derived CD117+ hematopoietic progenitor cells. Molecular Medicine Reports, 12, 6969-6975. https://doi.org/10.3892/mmr.2015.4320
MLA
Xu, Y., Jiang, D., Hu, Y., Li, Y., Zhang, X., Wang, J., Wang, Y."Fms‑like tyrosine kinase 3 ligand is required for thymic dendritic cell generation from bone marrow‑derived CD117+ hematopoietic progenitor cells". Molecular Medicine Reports 12.5 (2015): 6969-6975.
Chicago
Xu, Y., Jiang, D., Hu, Y., Li, Y., Zhang, X., Wang, J., Wang, Y."Fms‑like tyrosine kinase 3 ligand is required for thymic dendritic cell generation from bone marrow‑derived CD117+ hematopoietic progenitor cells". Molecular Medicine Reports 12, no. 5 (2015): 6969-6975. https://doi.org/10.3892/mmr.2015.4320
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team